Search Results for: Collplant

CollPlant to list on NASDAQ

Israeli human tissue repair company CollPlant is shortly to list on NASDAQ. Collplant uses tobacco plant DNA to develop and manufacture collagen-based regenerative medical treatments and bio-ink used in 3D printing of human tissues and organs. http://www.calcalistech.com/ctech/articles/0,7340,L-3730753,00.html

Posted in Economy & Business | Leave a comment

3D-printed lung transplants

Israel’s CollPlant has licensed US’s United Therapeutics to use CollPlant’s 3D bio-printing technology to manufacture lung transplants. The multi-million-dollar agreement can be expanded to print up to three additional organs. CollPlant will initially supply the necessary bio-ink https://ir.collplant.com/press-releases/detail/54/collplant-and-united-therapeutics-announce-global-licensing

Posted in Israel's Medical Achievements | Leave a comment

Go-ahead for bio-ink

Israel’s CollPlant (see here) is developing a proprietary rhCollagen-based formulations intended for use as bio-ink for the 3D printing of tissues and life savings organs.  It has now received grant approval (up to $1.2 million) of additional finance from the … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

rhCollagen factory opens

I’ve reported previously (see here) on Israel’s Collplant and its proprietary plant-based technology to produce rhCollagen (recombinant human collagen). CollPlant has just opened a new facility in Rehovot, for producing rhCollagen to make tissue repair products and 3D printing of … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

3D organ bio-printing

I reported previously (Jun 5) that Israel’s Collplant was developing a bio-ink that could 3D print tissues and organs. Collplant has now setup a division to produce the ink, which could eventually be the answer for patients desperately waiting for … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

European approval for tendon pain treatment

Israel’s CollPlant has been awarded the EU CE Mark for VergenixSTR, a soft tissue repair matrix for the treatment of tendinopathy (tendon injury or disease and associated pain).  VergenixSTR is based on CollPlant’s proprietary plant-based collagen technology. http://www.globes.co.il/en/article-collplant-awarded-eu-ce-mark-for-tendinopathy-treatment-1001156788

Posted in Israel's Medical Achievements | Leave a comment

Successful trials of Tennis Elbow treatment

Israel’s Collplant has reported positive results of trials of its Vergenix STR treatment for inflammation of the elbow tendon – commonly referred to as tennis elbow.  Most of the 40 patients reported less pain and disability – far better than … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Research into 3D organ printing

Israel’s Chief Scientist has awarded NIS 5.6 million to Israel’s Collplant.  It will help finance projects, including the development of plant-based collagen and formulations intended for use as BioInk for 3D printing of tissues and organs. http://www.globes.co.il/en/article-collplant-awarded-bio-ink-grant-for-3d-organ-tissue-printing-1001128604

Posted in Israel's Medical Achievements | Leave a comment

Vegetable collagen gel to treat wounds

(Thanks to Atid-EDI) Israeli health organization Maccabi is to commence trials of the Vergenix flowable gel developed by Israel’s CollPlant. Two Maccabi wound clinics will use Vergenix to treat patients with chronic leg ulcers. Vergenix is based on CollPlant’s plant-based … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

China invests in Israeli collagen

Israel’s Collplant has received a 10% investment from China’s Trauwin who will market Collplant’s products in China. Collagen is the most abundant protein in mammals and is used to repair damaged muscles and wounds. http://www.globes.co.il/serveen/globes/docview.asp?did=1000882901&fid=1725

Posted in Economy & Business | Leave a comment